Catalent Completes Expansion at Singapore Clinical Supply Facility


Applied Clinical Trials

Catalent Pharma Solutions announced the completion of a two-year, $4.6 million expansion at its Singapore clinical supply facility. As Catalents first Asia-Pacific region facility, it has provided additional GMP space for secondary packaging, has doubled ambient storage, and quadrupled cold storage capacity.

Read the full release here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.